Global Clinical Trials for Alzheimer's Disease: Design, Implementation, and Standardization
Editat de Menghis Bairu, Michael Weineren Limba Engleză Hardback – 24 noi 2013
- Written by leading experts with hands-on experience in designing and running global Alzheimer’s disease and other neurodegenerative diseases clinical trials
- A step-by-step guide that provides critical information on the design, conduct and standardization necessary to effectively execute clinical trials and accelerate drug development in this area
- Includes practical examples, ethical considerations, lessons learned and other valuable tools to aid the planning and implementation of Alzheimer’s disease global clinical trials in emerging markets and developing countries
Preț: 717.35 lei
Preț vechi: 755.11 lei
-5% Nou
Puncte Express: 1076
Preț estimativ în valută:
137.28€ • 144.42$ • 114.55£
137.28€ • 144.42$ • 114.55£
Carte tipărită la comandă
Livrare economică 09-23 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780124114647
ISBN-10: 0124114644
Pagini: 432
Ilustrații: 25 illustrations
Dimensiuni: 152 x 229 x 33 mm
Greutate: 0.82 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0124114644
Pagini: 432
Ilustrații: 25 illustrations
Dimensiuni: 152 x 229 x 33 mm
Greutate: 0.82 kg
Editura: ELSEVIER SCIENCE
Public țintă
Targets those individuals worldwide who are involved in clinical trials in AD, dementia and other neurodegenerative diseases, including scientists, physicians, regulators, safety officers, biostatisticians, data managers and more who plan and execute Alzheimer’s Disease clinical trials in and for developing companies.Cuprins
Section I – Global Alzheimer’s Disease Clinical Trials
Ch 1 – Introduction and Overview of Global Clinical Trials
Ch 2 – Dementia and Neurodegenerative Diseases: Global and Local Public Health Burden
Section II – Challenges and Opportunities to conduct Alzheimer’s Disease Trials
Ch 3 – Global Issues in Drug Development
Ch 4 – Patient Populations and Evolution of Diagnostic and Therapeutic Standards
Ch 5 – Opportunities for Standardization of Diagnostic and Outcome Measures
Section III – Operationalization of Global Alzheimer’s Disease Trials
Ch 6 - The Increasing Competition for Clinical Trial Sites and Traditional Markets – Issues and Opportunities
Section IV – Enhancing Low and Middle Income Countries Capacities
Ch 7 – Strengthening/Building AD Global Clinical Trial Sites – Lessons Learned
Section V – Pharmacogenomics and Ethical Considerations
Ch 8 – Definitions
Ch 9 – Pharmacogenomics in Clinical Trials
Ch 10 – Pharmacogenomics in AD Clinical Trials
Ch 11 – Conduct of Global Clinical Trials in Vulnerable Populations (Ethical Considerations)
Ch 12 – Next Steps Towards Global Clinical Trials of CNS Disease
Section VI – Human Resources Planning
Ch 13 – Talent Management
Section VII – Appendices
Ch 14 – Useful Online Appendices
Ch 1 – Introduction and Overview of Global Clinical Trials
Ch 2 – Dementia and Neurodegenerative Diseases: Global and Local Public Health Burden
Section II – Challenges and Opportunities to conduct Alzheimer’s Disease Trials
Ch 3 – Global Issues in Drug Development
Ch 4 – Patient Populations and Evolution of Diagnostic and Therapeutic Standards
Ch 5 – Opportunities for Standardization of Diagnostic and Outcome Measures
Section III – Operationalization of Global Alzheimer’s Disease Trials
Ch 6 - The Increasing Competition for Clinical Trial Sites and Traditional Markets – Issues and Opportunities
Section IV – Enhancing Low and Middle Income Countries Capacities
Ch 7 – Strengthening/Building AD Global Clinical Trial Sites – Lessons Learned
Section V – Pharmacogenomics and Ethical Considerations
Ch 8 – Definitions
Ch 9 – Pharmacogenomics in Clinical Trials
Ch 10 – Pharmacogenomics in AD Clinical Trials
Ch 11 – Conduct of Global Clinical Trials in Vulnerable Populations (Ethical Considerations)
Ch 12 – Next Steps Towards Global Clinical Trials of CNS Disease
Section VI – Human Resources Planning
Ch 13 – Talent Management
Section VII – Appendices
Ch 14 – Useful Online Appendices
Recenzii
"Written and edited by internationally recognized clinician-scientists, this useful book is a welcome addition to the field…This is a practical and useful reference for conducting international clinical trials in Alzheimer's disease. Researchers that are planning and conducting global clinical trials would benefit from having access to this excellent reference." Rating: 3 Stars --Doody.com, April 11, 2014